Diagnosing preclinical and clinical Alzheimer's disease with visual atrophy scales in the clinical practice

Diagnosing preclinical and clinical Alzheimer's disease with visual atrophy scales in the clinical practice

Background Visual atrophy scales from the medial temporal region are auxiliary biomarkers of neurodegeneration in Alzheimer's disease (AD). Therefore, they may correlate with progression from cognitively unimpaired (CU) status to mild cognitive impairment (MCI) and AD, and they becom...

Full description

Saved in:
Bibliographic Details
Main Authors: Karen Luiza Ramos Socher, Douglas Mendes Nunes, Deborah Cristina P. Lopes, Artur Martins Novaes Coutinho, Daniele de Paula Faria, Paula Squarzoni, Geraldo Busatto Filho, Carlos Alberto Buchpiguel, Ricardo Nitrini, Sonia Maria Dozzi Brucki
Format: Article
Language:English
Published: Thieme Revinter Publicações 2025-01-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Alzheimer Disease
Magnetic Resonance Imaging
Atrophy
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1802960
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Visual atrophy scales from the medial temporal region are auxiliary biomarkers of neurodegeneration in Alzheimer's disease (AD). Therefore, they may correlate with progression from cognitively unimpaired (CU) status to mild cognitive impairment (MCI) and AD, and they become a valuable tool for diagnostic accuracy.
ISSN:0004-282X
1678-4227

Similar Items